These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33342749)

  • 1. Overall Survival in Metastatic Breast Cancer Patients in the Third Millennium: Results of the COSMO Study.
    La Verde N; Collovà E; Blasi L; Pinotti G; Palumbo R; Bonotto M; Garrone O; Brunello A; Rimanti A; Bareggi C; Zaniboni A; Frassoldati A; Foglietta J; Berardi R; Moretti A; Farina G; Porcu L; Barni S
    Clin Breast Cancer; 2021 Oct; 21(5):e489-e496. PubMed ID: 33342749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study.
    Marshall EM; Bertaut A; Desmoulins I; Darut-Jouve A; Ponnelle T; Poillot ML; Beltjens F; Arveux P
    Breast J; 2017 Mar; 23(2):138-145. PubMed ID: 27935232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016.
    Deluche E; Antoine A; Bachelot T; Lardy-Cleaud A; Dieras V; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Courtinard C; Perol D; Robain M; Delaloge S
    Eur J Cancer; 2020 Apr; 129():60-70. PubMed ID: 32135312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort.
    Gobbini E; Ezzalfani M; Dieras V; Bachelot T; Brain E; Debled M; Jacot W; Mouret-Reynier MA; Goncalves A; Dalenc F; Patsouris A; Ferrero JM; Levy C; Lorgis V; Vanlemmens L; Lefeuvre-Plesse C; Mathoulin-Pelissier S; Petit T; Uwer L; Jouannaud C; Leheurteur M; Lacroix-Triki M; Cleaud AL; Robain M; Courtinard C; Cailliot C; Perol D; Delaloge S
    Eur J Cancer; 2018 Jun; 96():17-24. PubMed ID: 29660596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Features Associated With Long-Term Survival in Patients With Metastatic Breast Cancer.
    Klar N; Rosenzweig M; Diergaarde B; Brufsky A
    Clin Breast Cancer; 2019 Aug; 19(4):304-310. PubMed ID: 30827763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival Impact of Locoregional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancers in a Large Multicentric Cohort Study: A Propensity Score-Matched Analysis.
    Pons-Tostivint E; Kirova Y; Lusque A; Campone M; Geffrelot J; Mazouni C; Mailliez A; Pasquier D; Madranges N; Firmin N; Crouzet A; Gonçalves A; Jankowski C; De La Motte Rouge T; Pouget N; de La Lande B; Mouttet-Boizat D; Ferrero JM; Uwer L; Eymard JC; Mouret-Reynier MA; Petit T; Robain M; Filleron T; Cailliot C; Dalenc F
    Ann Surg Oncol; 2019 Feb; 26(2):356-365. PubMed ID: 30539492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis and Treatment of Metastatic Breast Cancer From A Real-World Scenario in China: A Retrospective Cohort Study.
    Xie Y; Ma J; Xia X; Zheng H; Gou Q
    Cancer Control; 2022; 29():10732748221130568. PubMed ID: 36164749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer bone metastases at initial diagnosis: a SEER-based study.
    Li X; Zhang X; Liu J; Shen Y
    BMC Cancer; 2020 Nov; 20(1):1102. PubMed ID: 33187507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring prognostic factors for HER2-positive metastatic breast cancer: a retrospective cohort study in a major Swiss hospital.
    Bringolf L; Pestalozzi B; Fink D; Dedes K
    Swiss Med Wkly; 2016; 146():w14393. PubMed ID: 28102883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors.
    Berghoff AS; Bago-Horvath Z; Ilhan-Mutlu A; Magerle M; Dieckmann K; Marosi C; Birner P; Widhalm G; Steger GG; Zielinski CC; Bartsch R; Preusser M
    Br J Cancer; 2012 Oct; 107(9):1454-8. PubMed ID: 23047551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of eribulin for metastatic breast cancer based on localization of specific secondary metastases: a post hoc analysis.
    O'Shaughnessy J; Cortes J; Twelves C; Goldstein LJ; Alexis K; Xie R; Barrios C; Ueno T
    Sci Rep; 2020 Jul; 10(1):11203. PubMed ID: 32641747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review.
    Kobayashi T; Ichiba T; Sakuyama T; Arakawa Y; Nagasaki E; Aiba K; Nogi H; Kawase K; Takeyama H; Toriumi Y; Uchida K; Kobayashi M; Kanehira C; Suzuki M; Ando N; Natori K; Kuraishi Y
    Breast Cancer; 2012 Jul; 19(3):218-37. PubMed ID: 22532161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand.
    Lao C; Kuper-Hommel M; Elwood M; Campbell I; Edwards M; Lawrenson R
    Breast Cancer; 2021 Mar; 28(2):387-397. PubMed ID: 33044617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capecitabine after anthracycline and taxane exposure in HER2-negative metastatic breast cancer patients: response, survival and prognostic factors.
    Gilabert M; Bertucci F; Esterni B; Madroszyk A; Tarpin C; Jacquemier J; Extra JM; Viens P; Gonçalves A
    Anticancer Res; 2011 Mar; 31(3):1079-86. PubMed ID: 21498742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
    Deniz M; DeGregorio A; DeGregorio N; Bekes I; Widschwendter P; Schochter F; Ernst K; Scholz C; Bauer EC; Aivazova-Fuchs V; Weissenbacher T; Kost B; Jueckstock J; Andergassen U; Steidl J; Trapp E; Fasching PA; Häberle L; Beckmann MW; Schneeweiss A; Schrader I; Janni W; Rack B; Friedl TW
    Breast; 2019 Apr; 44():81-89. PubMed ID: 30690254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies.
    Gennari A; Conte P; Rosso R; Orlandini C; Bruzzi P
    Cancer; 2005 Oct; 104(8):1742-50. PubMed ID: 16149088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age related influence of triple receptor status on metastatic breast cancer post relapse survival.
    Todorovic-Rakovic N; Neskovic-Konstantinovic Z
    J BUON; 2013; 18(4):851-8. PubMed ID: 24344008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metastatic breast cancer in young women: a population-based cohort study to describe risk and prognosis.
    Tjokrowidjaja A; Lee CK; Houssami N; Lord S
    Intern Med J; 2014 Aug; 44(8):764-70. PubMed ID: 24863750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort.
    Darlix A; Louvel G; Fraisse J; Jacot W; Brain E; Debled M; Mouret-Reynier MA; Goncalves A; Dalenc F; Delaloge S; Campone M; Augereau P; Ferrero JM; Levy C; Fumet JD; Lecouillard I; Cottu P; Petit T; Uwer L; Jouannaud C; Leheurteur M; Dieras V; Robain M; Chevrot M; Pasquier D; Bachelot T
    Br J Cancer; 2019 Dec; 121(12):991-1000. PubMed ID: 31719684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes, Treatment Patterns, and Health Resource Utilization Among Metastatic Breast Cancer Patients with Germline BRCA1/2 Mutation: A Real-World Retrospective Study.
    Quek RGW; Mardekian J
    Adv Ther; 2019 Mar; 36(3):708-720. PubMed ID: 30656571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.